We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
120 hedge funds and large institutions have $293M invested in ANI Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
58% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 33
13% more capital invested
Capital invested by funds: $259M → $293M (+$34.6M)
3.97% more ownership
Funds ownership: 53.33% → 57.3% (+4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 126 → 120 (-6)
19% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 16
67% less call options, than puts
Call options by funds: $614K | Put options by funds: $1.86M
Holders
120
Holders Change
-6
Holders Change %
-4.76%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
52
Reduced
33
Closed
16
Calls
$614K
Puts
$1.86M
Net Calls
-$1.25M
Net Calls Change
+$134K
Top Buyers
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$7.05M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$4.68M |
| 3 |
BlackRock
New York
|
+$3.61M |
| 4 |
Goldman Sachs
New York
|
+$3.47M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$2.94M |
Top Sellers
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$7.61M |
| 2 |
Renaissance Technologies
New York
|
-$2.49M |
| 3 |
Millennium Management
New York
|
-$1.33M |
| 4 |
Two Sigma Investments
New York
|
-$1.26M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.05M |
